Kidney dysfunction and left ventricular assist device support: A comprehensive perioperative review

CardioRenal Medicine

Volumn 5, Issue 1, 2015, Pages 48-60

  Coffin, Samuel T ^a   Waguespack, Dia R ^a   Haglund, Nicholas A ^a   Maltais, Simon ^a   Dwyer, Jamie P ^a   Keebler, Mary E ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Heart failure; Kidney injury; Ventricular assist device

Indexed keywords

ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; HEART FAILURE; HUMAN; IMPLANTATION; KIDNEY DYSFUNCTION; LEFT VENTRICULAR ASSIST DEVICE; MORBIDITY; MORTALITY; NONHUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW;

EID: 84923335870     PISSN: 16643828     EISSN: 16645502     Source Type: Journal    
DOI: 10.1159/000369589     Document Type: Review

References (74)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, et al: Executive summary: heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013; 127: 143-152.
2. Patel UD, Hernandez AF, Liang L, Peterson ED, LaBresh KA, Yancy CW, Albert NM, Ellrodt G, Fonarow GC: Quality of care and outcomes among patients with heart failure and chronic kidney disease: a Get With the Guidelines-Heart Failure Program study. Am Heart J 2008; 156: 674-681.
3. Zannad F, Mebazaa A, Juilliere Y, Cohen-Solal A, Guize L, Alla F, Rouge P, Blin P, Barlet MH, Paolozzi L, Vincent C, Desnos M, Samii K: Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study. Eur J Heart Fail 2006; 8: 697-705.
4. Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM: Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004; 43: 61-67.
5. Lund LH, Edwards LB, Kucheryavaya AY, Dipchand AI, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Yusen RD, Stehlik J: The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report-2013; focus theme: age. J Heart Lung Transplant 2013; 32: 951-964.
6. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Miller MA, Timothy BJ, Young JB: Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant 2014; 33: 555-564.
7. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM III, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH: Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241-2251.
8. Uriel N, Jorde UP, Woo PS, Jiang J, Clerkin K, Takayama H, Naka Y, Schulze PC, Mancini DM: Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation. J Heart Lung Transplant 2013; 32: 188-195.
9. Pal JD, Piacentino V, Cuevas AD, Depp T, Daneshmand MA, Hernandez AF, Felker GM, Lodge AJ, Rogers JG, Milano CA: Impact of left ventricular assist device bridging on posttransplant outcomes. Ann Thorac Surg 2009; 88: 1457-1461.
10. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK: INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009; 28: 535-541.
11. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53: 589-596.
12. Welp H, Rukosujew A, Tjan TD, Hoffmeier A, Kosek V, Scheld HH, Drees G: Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure. Thorac Cardiovasc Surg 2010; 58(suppl 2):S185-S188.
13. Kihara S, Litwak KN, Nichols L, Litwak P, Kameneva MV, Wu Z, Kormos RL, Griffith BP: Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist. Ann Thorac Surg 2003; 75: 178-183.
14. Ohnishi H, Itoh T, Nishinaka T, Tatsumi E, Fukuda T, Oshikawa M, Shioya K, Tsukiya T, Takewa Y, Homma A, Uesho K, Sato K, Takano H, Taenaka Y: Morphological changes of the arterial systems in the kidney under prolonged continuous flow left heart bypass. Artif Organs 2002; 26: 974-979.
15. Ootaki C, Yamashita M, Ootaki Y, Kamohara K, Weber S, Klatte RS, Smith WA, Massiello AL, Emancipator SN, Golding LA, Fukamachi K: Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. J Thorac Cardiovasc Surg 2008; 136: 150-158.
16. Saito S, Nishinaka T, Westaby S: Hemodynamics of chronic nonpulsatile flow: implications for LVAD development. Surg Clin North Am 2004; 84: 61-74.
17. Thalmann M, Schima H, Wieselthaler G, Wolner E: Physiology of continuous blood flow in recipients of rotary cardiac assist devices. J Heart Lung Transplant 2005; 24: 237-245.
18. Iwashima Y, Yanase M, Horio T, Seguchi O, Murata Y, Fujita T, Toda K, Kawano Y, Nakatani T: Effect of pulsatile left ventricular assist system implantation on Doppler measurements of renal hemodynamics in patients with advanced heart failure. Artif Organs 2012; 36: 353-358.
19. Haglund NA, Feurer ID, Dwyer JP, Stulak JM, DiSalvo TG, Keebler ME, Schlendorf KH, Wigger MA, Maltais S: Does renal dysfunction and method of bridging support influence heart transplant graft survival Ann Thorac Surg 2014; 98: 835-841.
20. Farrar DJ, Hill JD: Recovery of major organ function in patients awaiting heart transplantation with Thoratec ventricular assist devices. Thoratec Ventricular Assist Device Principal Investigators. J Heart Lung Transplant 1994; 13: 1125-1132.
21. James KB, McCarthy PM, Jaalouk S, Bravo EL, Betkowski A, Thomas JD, Nakatani S, Fouad-Tarazi FM: Plasma volume and its regulatory factors in congestive heart failure after implantation of long-term left ventricular assist devices. Circulation 1996; 93: 1515-1519.
22. Hasin T, Topilsky Y, Schirger JA, Li Z, Zhao Y, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Joyce L, Daly R, Park SJ, Kushwaha SS: Changes in renal function after implantation of continuousflow left ventricular assist devices. J Am Coll Cardiol 2012; 59: 26-36.
23. Sandner SE, Zimpfer D, Zrunek P, Dunkler D, Schima H, Rajek A, Grimm M, Wolner E, Wieselthaler GM: Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. J Heart Lung Transplant 2008; 27: 469-473.
24. Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, Grimm M, Wolner E, Wieselthaler GM: Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 2009; 87: 1072-1078.
25. Kamdar F, Boyle A, Liao K, Colvin-Adams M, Joyce L, John R: Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant 2009; 28: 352-359.
26. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH: End-organ function in patients on long-term circulatory support with continuous-or pulsatile-flow assist devices. J Heart Lung Transplant 2007; 26: 815-818.
27. Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steidley DE, Ewald GA, Sundareswaran KS, Farrar DJ, Slaughter MS: Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 2012; 5: 241-248.
28. Brisco MA, Kimmel SE, Coca SG, Putt ME, Jessup M, Tang WW, Parikh CR, Testani JM: Prevalence and prognostic importance of changes in renal function after mechanical circulatory support. Circ Heart Fail 2014; 7: 68-75.
29. Demirozu ZT, Etheridge WB, Radovancevic R, Frazier OH: Results of HeartMate II left ventricular assist device implantation on renal function in patients requiring post-implant renal replacement therapy. J Heart Lung Transplant 2011; 30: 182-187.
30. Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, McGee EC Jr, Cotts WG, DeNofrio D, Pham DT, Farrar DJ, Pagani FD: Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011; 57: 1890-1898.
31. Yoshioka D, Sakaguchi T, Saito S, Miyagawa S, Nishi H, Yoshikawa Y, Fukushima S, Saito T, Daimon T, Ueno T, Kuratani T, Sawa Y: Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function. Circ J 2012; 76: 1631-1638.
32. Deo SV, Sharma V, Altarabsheh SE, Hasin T, Dillon J, Shah IK, Durham LA 3rd, Stulak JM, Daly RC, Joyce LD, Park SJ: Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device. Heart Lung Circ 2014; 23: 229-233.
33. Kishimoto T, Maekawa M, Abe Y, Yamamoto K: Intrarenal distribution of blood flow and renin release during renal venous pressure elevation. Kidney Int 1973; 4: 259-266.
34. Ruggenenti P, Remuzzi G: Worsening kidney function in decompensated heart failure: treat the heart, don't mind the kidney. Eur Heart J 2011; 32: 2476-2478.
35. Ronco C, Di Lullo L: Cardiorenal syndrome. Heart Fail Clin 2014; 10: 251-280.
36. Valika AA, Gheorghiade M: Ace inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature. Heart Fail Rev 2013; 18: 135-140.
37. McCullough PA: Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51: 1419-1428.
38. Wu X, Zhang W, Ren H, Chen X, Xie J, Chen N: Diuretics associated acute kidney injury: clinical and pathological analysis. Ren Fail 2014; 36: 1051-1055.
39. Ronco C, Cicoira M, McCullough PA: Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol 2012; 60: 1031-1042.
40. Borgi J, Tsiouris A, Hodari A, Cogan CM, Paone G, Morgan JA: Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation. Ann Thorac Surg 2013; 95: 163-169.
41. Feldman D, Pamboukian SV, Teuteberg JJ, et al; International Society for Heart and Lung Transplantation: The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 2013; 32: 157-187.
42. Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH: Predictors of acute renal dysfunction after ventricular assist device placement. J Card Fail 2009; 15: 874-881.
43. Topkara VK, Dang NC, Barili F, Cheema FH, Martens TP, George I, Bardakci H, Oz MC, Naka Y: Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant 2006; 25: 404-408.
44. Genovese EA, Dew MA, Teuteberg JJ, Simon MA, Bhama JK, Bermudez CA, Lockard KL, Winowich S, Kormos RL: Early adverse events as predictors of 1-year mortality during mechanical circulatory support. J Heart Lung Transplant 2010; 29: 981-988.
45. Vural KM: Ventricular assist device applications. Anadolu Kardiyol Derg 2008; 8(suppl 2):117-130.
46. Kellum JA, Lameire N; KDIGO AKI Guideline Work Group: Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care 2013; 17: 204.
47. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-2256.
48. Lowenstein J, Schacht RG, Baldwin DS: Renal failure in minimal change nephrotic syndrome. Am J Med 1981; 70: 227-233.
49. Patel AM, Adeseun GA, Ahmed I, Mitter N, Rame JE, Rudnick MR: Renal failure in patients with left ventricular assist devices. Clin J Am Soc Nephrol 2013; 8: 484-496.
50. Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, Starling RC, Chen L, Boyle AJ, Chillcott S, Adamson RM, Blood MS, Camacho MT, Idrissi KA, Petty M, Sobieski M, Wright S, Myers TJ, Farrar DJ; HeartMate II Clinical Investigators: Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010; 29(suppl):S1-S39.
51. Lehman LW, Saeed M, Moody G, Mark R: Hypotension as a risk factor for acute kidney injury in ICU patients. Comput Cardiol 2010; 37: 1095-1098.
52. Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, Geng RW: Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 2006; 354: 131-140.
53. Hsu TW, Liu JS, Hung SC, Kuo KL, Chang YK, Chen YC, Hsu CC, Tarng DC: Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia. JAMA Intern Med 2014; 174: 347-354.
54. Molnar MZ, Kalantar-Zadeh K, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Quarles DL, Kovesdy CP: Angiotensinconverting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol 2014; 63: 650-658.
55. Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med 1997; 337: 1512-1523.
56. Cox ZL, Calcutt MW, Morrison TB, Akers WS, Davis MB, Lenihan DJ: Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction. J Cardiovasc Pharmacol Ther 2013; 18: 433-438.
57. Rabindranath K, Adams J, Macleod AM, Muirhead N: Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007; 3:CD003773.
58. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; 2: 1-141.
59. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S: Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627-1638.
60. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20.
61. Guglielmi AA, Guglielmi KE, Bhat G, Siemeck R, Tatooles AJ: Peritoneal dialysis after left ventricular assist device placement. ASAIO J 2014; 60: 127-128.
62. Thomas BA, Logar CM, Anderson AE: Renal replacement therapy in congestive heart failure requiring left ventricular assist device augmentation. Perit Dial Int 2012; 32: 386-392.
63. Karamlou T, Welke KF, McMullan DM, Cohen GA, Gelow J, Tibayan FA, Mudd JM, Slater MS, Song HK: Combined heart-kidney transplant improves post-transplant survival compared with isolated heart transplant in recipients with reduced glomerular filtration rate: analysis of 593 combined heart-kidney transplants from the United Network Organ Sharing Database. J Thorac Cardiovasc Surg 2014; 147: 456-461.
64. Collins AJ, Foley RN, Herzog C, et al: US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 2011; 57(suppl 1):A8, e1-e526.
65. Sumida M, Doi K, Kinoshita O, Kimura M, Ono M, Hamasaki Y, Matsubara T, Ishii T, Yahagi N, Nangaku M, Noiri E: Perioperative plasma neutrophil gelatinase-associated lipocalin measurement in patients who undergo left ventricular assist device implantation surgery. Circ J 2014; 78: 1891-1899.
66. Baldwin JT, Mann DL: NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVEIT pilot trial. J Card Fail 2010; 16: 855-858.
67. Farrar DJ: Risk assessment and comparative effectiveness of left ventricular assist device (LVAD) and medical management (ROADMAP). ClinicalTrials.gov identifier: NCT01452802. http://clinicaltrials.gov/ct2/show/ NCT01452802.
68. Barbone A, Pini D, Ornaghi D, Visigalli MM, Ardino L, Bragato R, Curzi M, Cioccarelli SA, Di Diodoro L, Basciu A, Cappai A, Settepani F, Citterio E, Cappelleri A, Calcagnino M, Mangiavacchi M, Tarelli G, Lettino M, Vitali E: CircuLite Synergy ventricular assist device: a new approach to end-stage congestive heart failure (in Italian). G Ital Cardiol (Rome) 2014; 15: 116-122.
69. Umakanthan R, Haglund NA, Stulak JM, Joyce LD, Ahmad R, Keebler ME, Maltais S: Left thoracotomy HeartWare implantation with outflow graft anastomosis to the descending aorta: a simplified bridge for patients with multiple previous sternotomies. ASAIO J 2013; 59: 664-667.
70. Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, Bogaev RC, Frazier OH: Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 2011; 30: 849-853.
71. Rojas SV, Avsar M, Khalpey Z, Hanke JS, Haverich A, Schmitto JD: Minimally invasive off-pump left ventricular assist device exchange: anterolateral thoracotomy. Artif Organs 2014; 38: 539-542.
72. Schmitto JD, Rojas SV, Hanke JS, Avsar M, Haverich A: Minimally invasive left ventricular assist device explantation after cardiac recovery: surgical technical considerations. Artif Organs 2014; 38: 507-510.
73. Garcia SD, Mohite PN, Zych B, Sabashnikov A, Hards R, Simon AR, Bahrami T: Minimally invasive access for off-pump HeartWare left ventricular assist device explantation. Interact Cardiovasc Thorac Surg 2013; 17: 581-582.
74. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539.